Harrow, Inc. Other Receivables
Harrow, Inc. (HROW) had Other Receivables of $228.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Nontrade Receivables
us-gaap:OtherReceivables · last filed 2023-11-13
- 2023-09-30: Other Receivables $228.00K.
- 2023-06-30: Other Receivables $728.00K.
- 2023-03-31: Other Receivables $198.00K.
- 2022-12-31: Other Receivables $139.00K.
| Period end | Other Receivables |
|---|---|
| 2023-09-30 | $228.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $728.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $198.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $139.00K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |